# InspireMD, Inc. (NSPR) — delisting/forced [announced]
Source: SEC API (secapi.ai) · situation sit_7f399aae2ec0e2e686da · retrieved 2026-08-11T15:49:19.227Z

## Overview
InspireMD, Inc. is a medical device company in the surgical and medical instruments sector, trading on The Nasdaq Capital Market under the symbol NSPR.

On July 17, 2026, InspireMD, Inc. received notice from Nasdaq that it failed to maintain the minimum bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market under Listing Rule 5550(a)(2). Based on closing bid prices for the 30 consecutive business days from June 3, 2026 through July 16, 2026, the company no longer satisfied the minimum bid price requirement. Nasdaq has provided a 180-calendar-day compliance period, expiring January 13, 2027, during which the company must achieve a closing bid price of at least $1.00 per share for a minimum of ten consecutive business days to regain compliance. The company intends to actively monitor its stock price and evaluate options to regain compliance, including a potential reverse stock split.

## Terms
- Counterparty: The Nasdaq Stock Market LLC · Price/share: $1

## Key dates
- Announced 2026-07-23 · Expiry 2027-01-13

## Timeline
- 2026-07-23 · 8-K (0001493152-26-034430): 8-K - InspireMD, Inc. — *InspireMD, Inc. is a medical device company in the surgical and medical instruments sector, trading on The Nasdaq Capital Market under the symbol NSPR.* On July 17, 2026, InspireMD, Inc. received notice from Nasdaq that it failed to maintain the minimum bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market under Listing Rule 5550(a)(2). Based on closing bid prices for the 30 consecutive business days from June 3, 2026 through July 16, 2026, the company no longer satisfied the minimum bid price requirement. Nasdaq has provided a 180-calendar-day compliance period, expiring January 13, 2027, during which the company must achieve a closing bid price of at least $1.00 per share for a minimum of ten consecutive business days to regain compliance. The company intends to actively monitor its stock price and evaluate options to regain compliance, including a potential reverse stock split.
  https://www.sec.gov/Archives/edgar/data/1433607/0001493152-26-034430.txt

## Citations
- 0001493152-26-034430 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000149315226034430